Russell J. Cox, Director at Jazz Pharmaceuticals plc (JAZZ), sold 6,000 shares at $230.33 ($1.4M) on 2026-10-01, disclosed to the SEC on 2026-10-05.
Scheduled sale ($1.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | SELL | 2016-08-10 | $595K | — | Filing → |
| JAZZ | SELL | 2016-04-13 | $548K | — | Filing → |
| AGLE | BUY | 2016-04-12 | $70K | — | Filing → |